Baker Bros. Advisors Lp bought $60.0M of Kodiak Sciences (KOD)
Executed Dec 18 2025, disclosed Dec 19 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Dec 19 2025), the stock returned +2.7% (delay-adjusted); from the execution session (Dec 18 2025), -2.1%. Derived: entry at the session's open, exit at the close 20 sessions later.
Baker Bros. Advisors Lp (Other) filed 10 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 1 sale), most often in Kodiak Sciences Inc. (KOD). Across 7 priced purchase filings, the average 21-session return was +27.3% from execution and +5.7% from disclosure (delay-adjusted; derived). The largest single filing was $317.8M of CELC (3,100,000 sh across 2 lots, as filed), executed Jul 14.
Healthcare · Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeuti…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→247,090 sh across 4 lots
Exec Nov 4
Filed Nov 6 · 4:55 PM ET KODPURCHASE Kodiak Sciences Inc. $63.2M
713,746 sh across 18 lots
Exec Sep 28
Filed Sep 30 · 4:31 PM ET KODPURCHASE Kodiak Sciences Inc. $34.3M
410,749 sh across 16 lots
Exec Sep 28
Filed Sep 30 · 4:30 PM ET KODPURCHASE Kodiak Sciences Inc. $58.4M
804,731 sh across 24 lots
Exec Sep 28
Filed Sep 30 · 4:29 PM ET